• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者降低低密度脂蛋白胆固醇的治疗选择:执业护士的观点

Therapeutic options for lowering LDL-C in type 2 diabetes: a nurse practitioner's perspective.

作者信息

Lew Kelley Newlin, Kent Daniel J, Muñoz Angelica A, Melkus Gail D'Eramo

机构信息

School of Nursing, University of Connecticut, Storrs, Connecticut.

出版信息

J Am Assoc Nurse Pract. 2013 Sep;25(9):488-94. doi: 10.1002/2327-6924.12053.

DOI:10.1002/2327-6924.12053
PMID:24170653
Abstract

PURPOSE

The majority of patients with type 2 diabetes mellitus (T2DM) have multiple risk factors for cardiovascular disease (CVD). Low-density lipoprotein cholesterol (LDL-C) is a key therapeutic target to reduce CVD risk. This article reviews therapeutic strategies that nurse practitioners (NPs) may use in the management of patients with T2DM requiring lipid management.

DATA SOURCES

The evidence used in developing this review included evidence-based reviews, clinical trials, guidelines, and consensus statements. Relevant publications were identified through a search of the literature using PubMed and other search engines.

CONCLUSIONS

Lowering LDL-C levels may reduce CVD risk, but achieving goals can be challenging. Lifestyle modifications (including diet, exercise, and smoking cessation) are key components of lipid management and reduction of CVD risk. Statins can be effective to reduce lipids. However, patients may not achieve lipid goals with monotherapy or may experience intolerable adverse effects. Alternative statins or statins along with other lipid-lowering agents remain good options.

IMPLICATIONS FOR PRACTICE

Achieving LDL-C goals requires a comprehensive treatment plan that incorporates lifestyle and pharmacologic interventions. Patient commitment in setting goals and self-management is essential. NPs can play an important role in educating patients as well as prescribing appropriate treatments.

摘要

目的

大多数2型糖尿病(T2DM)患者存在多种心血管疾病(CVD)风险因素。低密度脂蛋白胆固醇(LDL-C)是降低CVD风险的关键治疗靶点。本文综述了执业护士(NP)在管理需要进行血脂管理的T2DM患者时可能采用的治疗策略。

数据来源

本综述所使用的证据包括循证综述、临床试验、指南和共识声明。通过使用PubMed和其他搜索引擎检索文献来识别相关出版物。

结论

降低LDL-C水平可能会降低CVD风险,但实现目标可能具有挑战性。生活方式的改变(包括饮食、运动和戒烟)是血脂管理和降低CVD风险的关键组成部分。他汀类药物可有效降低血脂。然而,患者单药治疗可能无法达到血脂目标,或者可能会出现难以耐受的不良反应。换用其他他汀类药物或他汀类药物与其他降脂药物联合使用仍是不错的选择。

对实践的启示

实现LDL-C目标需要一个综合的治疗计划,包括生活方式和药物干预。患者在设定目标和自我管理方面的投入至关重要。NP在教育患者以及开具适当治疗方案方面可以发挥重要作用。

相似文献

1
Therapeutic options for lowering LDL-C in type 2 diabetes: a nurse practitioner's perspective.2型糖尿病患者降低低密度脂蛋白胆固醇的治疗选择:执业护士的观点
J Am Assoc Nurse Pract. 2013 Sep;25(9):488-94. doi: 10.1002/2327-6924.12053.
2
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.在管理式医疗环境中,以低高密度脂蛋白胆固醇为靶点降低残余心血管风险。
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1.
3
The nurse practitioner's role in helping patients achieve lipid goals with statin therapy.执业护士在帮助患者通过他汀类药物治疗实现血脂目标方面的作用。
J Am Acad Nurse Pract. 2005 Jul;17(7):256-62. doi: 10.1111/j.1745-7599.2005.0043.x.
4
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.近期临床试验对美国国家胆固醇教育计划成人治疗专家组第三次指南的影响。
J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. doi: 10.1016/j.jacc.2004.07.001.
5
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.近期临床试验对美国国家胆固醇教育计划成人治疗专家组第三次指南的影响。
Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. doi: 10.1161/01.ATV.0000133317.49796.0E.
6
Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.他汀类药物治疗的糖尿病患者存在严重的高三酰甘油血症和残余血脂异常,这些患者心血管疾病风险最高,且达到非常低的 LDL-C 水平。
J Clin Lipidol. 2012 Sep-Oct;6(5):434-42. doi: 10.1016/j.jacl.2012.04.002. Epub 2012 Apr 12.
7
Dyslipidemia: management using optimal lipid-lowering therapy.血脂异常:采用最佳降脂疗法进行管理。
Ann Pharmacother. 2012 Oct;46(10):1368-81. doi: 10.1345/aph.1R127. Epub 2012 Oct 2.
8
Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.与其他他汀类药物相比,瑞舒伐他汀降低糖尿病患者低密度脂蛋白胆固醇的有效性及达到美国国家胆固醇教育计划成人治疗小组第三次指南低密度脂蛋白胆固醇目标的情况:一项使用美国电子病历数据集的回顾性研究
Curr Med Res Opin. 2007 Sep;23(9):2125-33. doi: 10.1185/030079907X219580.
9
Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?心血管风险降低:瑞舒伐他汀的最新试验告诉了我们什么?
Adv Ther. 2009 May;26(5):469-87. doi: 10.1007/s12325-009-0025-6. Epub 2009 May 14.
10
Management of dyslipidemia in diabetes.糖尿病血脂异常的管理
Cardiol Rev. 2006 May-Jun;14(3):125-35. doi: 10.1097/01.crd.0000188034.76283.5e.